CELULARITY INC

Profile

Company Names

CELULARITY INC

Addresses

170 PARK AVENUE, FLORHAM PARK, NJ 07932

170 PARK AVE, FLORHAM PARK, NJ 07932

Phone Numbers

(908) 768-2170

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$41,847,237.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-10-24 
$2,000,000.00 
$6,666,667.00 
$4,666,667.00 
Equity 
4
2025-07-30 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
3
2025-07-22 
$1,035,000.00 
$1,035,000.00 
$0.00 
Equity 
2
2025-07-21 
$6,812,230.00 
$6,812,230.00 
$0.00 
Debt 
1
2022-05-20 
$30,000,007.00 
$30,000,007.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
C. 
BEERS 
EXECUTIVE OFFICER
CELULARITY INC
JAY 
R. 
BLOOM 
DIRECTOR
TRIMARAN POLLO PARTNERS, L.L.C.   |  CELULARITY INC
STEPHEN 
A. 
BRIGIDO 
EXECUTIVE OFFICER
CELULARITY INC   |  INNOVATIVE MIDFOOT SOLUTIONS, INC.
PETER 
 
DIAMANDIS 
DIRECTOR
ATLAS THERAPEUTICS CORP   |  MYOS CORP   |  HYPERLOOP TECHNOLOGIES, INC.   |  MK STEM CELL INC.   |  PLANETARY POWER, INC.   |  PLANETARY RESOURCES, INC.   |  CELULARITY INC.   |  SINGULARITY EDUCATION GROUP   |  C19 CORP.   |  FOUNTAIN LIFE HOLDINGS, LLC   |  VAXXINITY, INC.   |  LIFEFORCE DIGITAL INC.   |  CELULARITY INC   |  FOUTAIN HEALTH INSURANCE INC.
JOSEPH 
 
DOSSANTOS 
EXECUTIVE OFFICER
CAMBRIDGE THERAPEUTIC TECHNOLOGIES, LLC   |  CELULARITY INC
KEARY 
 
DUNN 
EXECUTIVE OFFICER
CELULARITY INC
BRADLEY 
 
GLOVER 
EXECUTIVE OFFICER
CELULARITY INC
JOHN 
R. 
HAINES 
EXECUTIVE OFFICER
HEARTLAND BANCCORP   |  CELULARITY INC.   |  CELULARITY INC
ROBERT 
J. 
HARIRI 
EXECUTIVE OFFICER, DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.   |  ATLAS THERAPEUTICS CORP   |  MYOS CORP   |  PROVISTA DIAGNOSTICS INC.   |  CELULARITY INC
ANNE 
 
JONES 
EXECUTIVE OFFICER
BROTHER JUSTUS WHISKEY CO.   |  CELULARITY INC
DEAN 
C. 
KEHLER 
DIRECTOR
URBAN BRANDS, INC.   |  TRIMARAN POLLO PARTNERS, L.L.C.   |  CELULARITY INC   |  NIOCORP DEVELOPMENTS LTD
VINCENT 
 
LEVIEN 
DIRECTOR
CELULARITY INC
GEOFFREY 
 
LING 
DIRECTOR
MIND-X CORP.   |  SISU GLOBAL HEALTH INC.   |  CELULARITY INC
MARC 
 
MAZUR 
DIRECTOR
FIBROCELL SCIENCE, INC.   |  CELULARITY INC   |  SURO CAPITAL CORP.
DIANE 
 
PARKS 
DIRECTOR
TRISALUS LIFE SCIENCES, INC.   |  KURA ONCOLOGY, INC.   |  CELULARITY INC
ANDREW 
L. 
PECORA 
EXECUTIVE OFFICER
NEOSTEM, INC.   |  COTA, INC.   |  CALADRIUS BIOSCIENCES, INC.   |  CELULARITY INC
JOHN 
 
SCULLEY 
DIRECTOR
CAIVIS ACQUISTION CORP   |  OPENPEAK INC   |  MISFIT WEARABLES CORP   |  WATERMARK MEDICAL, INC.   |  WATERMARK MEDICAL HOLDINGS, INC.   |  PIVOT ACQUISITION CORP.   |  AUDAX HEALTH SOLUTIONS, INC.   |  MISFIT, INC.   |  CELULARITY INC.   |  RXADVANCE CORP   |  CELULARITY INC
ROBIN 
L. 
SMITH 
DIRECTOR
NEOSTEM, INC.   |  PROLUNG INC   |  SEELOS THERAPEUTICS, INC.   |  CELULARITY INC
LIM 
KOK 
THAY 
DIRECTOR
ELEVANCE RENEWABLE SCIENCES, INC.   |  CELULARITY INC
ANDREW 
C. 
VON ESCHENBACH 
DIRECTOR
BIOTIME INC   |  CELULARITY INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-10-24 
2025-08-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-07-30 
2025-08-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-07-21 
2025-08-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-07-22 
2022-05-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
A.G.P/ ALLIANCE GLOBAL PARTNERS
8361